Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroprotective Drugs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07167550
What this trial is testing

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

Who this might be right for
StrokeAcute StrokeIschemic Stroke+2 more
Tatchempharmpreparaty, JSC 184
Not applicableStudy completedNCT00027040
What this trial is testing

Decreased Mental Function Associated With HIV

Who this might be right for
Cognitive DisordersHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)UnknownNCT03546283
What this trial is testing

Neuroprotectant for Hypertensive Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
Rong Hu, MD 422
Testing effectiveness (Phase 2)Study completedNCT00630396
What this trial is testing

Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke

Who this might be right for
Stroke, Acute
David Hess, MD 60
Testing effectiveness (Phase 2)Study completedNCT01854294
What this trial is testing

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genervon Biopharmaceuticals, LLC 12
Not applicableNot Yet RecruitingNCT07260760
What this trial is testing

Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Qianfoshan Hospital 600
Testing effectiveness (Phase 2)Study completedNCT06700824
What this trial is testing

A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke

Who this might be right for
Endovascular ThrombectomyIschemic Cerebrovascular Accident
Organ, Tissue, Regeneration, Repair and Replacement 60
Not applicableStudy completedNCT05807503
What this trial is testing

Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

Who this might be right for
TBI (Traumatic Brain Injury)
Pomeranian Medical University Szczecin 56
Testing effectiveness (Phase 2)WithdrawnNCT02113176
What this trial is testing

Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage

Who this might be right for
Subarachnoid Aneurysm Hemorrhage
University at Buffalo
Large-scale testing (Phase 3)Study completedNCT02793687
What this trial is testing

Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy

Who this might be right for
Ischemic Stroke
Pharmasoft 150
Early research (Phase 1)Study completedNCT03520517
What this trial is testing

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT05367362
What this trial is testing

Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
State University of New York at Buffalo
Large-scale testing (Phase 3)UnknownNCT05124353
What this trial is testing

Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Who this might be right for
Stroke, Acute, Ischemic
Pomeranian Medical University Szczecin 100
Not applicableEnded earlyNCT01486459
What this trial is testing

A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Barwon Health 7
Testing effectiveness (Phase 2)Study completedNCT05585606
What this trial is testing

Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke (AIS)
Silver Creek Pharmaceuticals 120
Not applicableEnded earlyNCT01502748
What this trial is testing

Endovascular Magnesium Sampling in Acute Stroke

Who this might be right for
Acute Stroke
University of Southern California 2
Testing effectiveness (Phase 2)Looking for participantsNCT06744361
What this trial is testing

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Who this might be right for
Out-of-hospital Cardiac Arrest (OHCA)
Christian Hassager 282
Not applicableStudy completedNCT05297851
What this trial is testing

Cytoflavin in Combination With Reperfusion in Stroke Patients

Who this might be right for
Acute Stroke
POLYSAN Scientific & Technological Pharmaceutical Company 200
Testing effectiveness (Phase 2)Study completedNCT00649961
What this trial is testing

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

Who this might be right for
Premature BirthBrain Injury
Imperial College London 18
Early research (Phase 1)WithdrawnNCT05032781
What this trial is testing

Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention

Who this might be right for
Stroke, Ischemic
Northwell Health
Next Page